Glycomimetics inc.

Major-Pharmaceuticals

GLYC


9708 Medical Center Drive
Rockville , MD 20850

Executive/
Director

Price

  • Last Close
  • $ 0.18
    $ +0.01 3.55 %
    Aug 29, 2024
  • 52-Week High/Low
  • $3.49 - $0.17
  • YTD
  • -92.6%

  • Trading Volume
  • 26,187
  • Market Cap Full
  • $ 11.6M
  • Shares Outstanding
  • 64.4M
    Nov 1, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 15.6% 4.2% -11% -3.3% 31.6% -5% -19.7% -20.8% -58.4% 27.1%
Q2 -4.5% 22% 105.5% 1.3% -3.4% 4% -23.2% -47.4% 38.1% -2.6%
Q3 -29.6% -1.7% 25.4% -8.7% -63.5% 8% -5.6% -8.3% -13.8% -
Q4 2.1% -14.7% 24.6% -33.7% 23.9% 22.5% -34.3% 450.9% 66.2% -
J F M A M J J A S O N D
2024 27.1% -3.7% 3.8% -1.3% - - - - - - - -
2023 -4% -47.1% -18.2% 11.1% 32.9% -6.5% -5.8% -2.4% -6.3% -16.7% 31.2% 43.9%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%-21%7%175%-44%-42%-31%-62%110%-22%-93%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.37 0.40 0.34 -0.33 -0.33 -0.18 -0.28 -0.28 -0.17
Q2 0.51 0.41 0.30 -0.26 -0.37 -0.32 -0.28 -0.25 -0.13
Q3 0.38 0.34 0.24 -0.27 -0.31 -0.29 -0.34 -0.16 -0.14
Q4 0.47 0.36 0.27 -0.32 -0.33 -0.33 -0.33 -0.20 -
A 1.7 1.5 1.2 -1.2 -1.3 -1.1 -1.2 -0.9 -0.44

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 43.2 43.6 51.5 52.3 64.2
Jun 42.5 43.2 43.6 51.5 52.4 64.2
Sep 43.1 43.2 47.7 51.5 52.4 64.3
Dec 43.1 43.4 47.8 51.7 52.4 64.4

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - 0.5 3.3 - -
Total Asset Turnover - - 0.1 - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage - - 52 20.3 13
Equity multiplier - - - - -